CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid
RZ Liu, E Garcia, DD Glubrecht, HY Poon, JR Mackey… - Molecular cancer, 2015 - Springer
Background Clinical trials designed to test the efficacy of retinoic acid (RA) as an adjuvant
for the treatment of solid cancers have been disappointing, primarily due to RA resistance …
for the treatment of solid cancers have been disappointing, primarily due to RA resistance …
[HTML][HTML] Retinoic acid receptor α promotes autophagy to alleviate liver ischemia and reperfusion injury
C Zhong, LY Pu, MM Fang, Z Gu, JH Rao… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To study the role of autophagy and the relationship between retinoic acid receptor α
(RARα) and autophagy in liver ischemia and reperfusion (IR) injury. METHODS: All-trans …
(RARα) and autophagy in liver ischemia and reperfusion (IR) injury. METHODS: All-trans …
[HTML][HTML] CRABP-II-and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid
SL Xia, ML Wu, H Li, JH Wang, NN Chen, XY Chen… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Glioblastomas respond differently to all-trans retinoic acid (RA) for unknown reasons.
Because CRABP-II and FABP5 mediate RA intracellular signaling respectively and lead to …
Because CRABP-II and FABP5 mediate RA intracellular signaling respectively and lead to …
Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis
N Liu, P Li, S Zang, Q Liu, D Ma, X Sun, C Ji - PLoS One, 2015 - journals.plos.org
The proto-oncogene c-Myc plays critical roles in human malignancies including chronic
myeloid leukemia (CML), suggesting that the discovery of specific agents targeting c-Myc …
myeloid leukemia (CML), suggesting that the discovery of specific agents targeting c-Myc …